Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Mdp Briceño Casado"'
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a5719b83ad02dd47686abc225c8c300
https://doi.org/10.1136/ejhpharm-2023-eahp.74
https://doi.org/10.1136/ejhpharm-2023-eahp.74
Publikováno v:
Section 6: Education and research.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c0ae50ed4bf22dbec60d3c49fdd54e6
https://doi.org/10.1136/ejhpharm-2023-eahp.341
https://doi.org/10.1136/ejhpharm-2023-eahp.341
Autor:
MDP Briceño Casado, MD Gil-Sierra, C Moreno Ramos, B de la Calle-Riaguas, CM Cuadros-Martinez
Publikováno v:
Section 5: Patient safety and quality assurance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b279d6522a3dcb3c2c80d1ce12406fc
https://doi.org/10.1136/ejhpharm-2023-eahp.247
https://doi.org/10.1136/ejhpharm-2023-eahp.247
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c420fae1c2e7409cef5ed41ffea3853
https://doi.org/10.1136/ejhpharm-2023-eahp.70
https://doi.org/10.1136/ejhpharm-2023-eahp.70
Autor:
MDP Briceño Casado, MD Gil-Sierra, CM Cuadros-Martinez, B De La Calle-Riaguas, R Gavira-Moreno
Publikováno v:
Late breaking abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c2e413dca323bae0d660ecb25081d78
https://doi.org/10.1136/ejhpharm-2023-eahp.386
https://doi.org/10.1136/ejhpharm-2023-eahp.386
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::963e34ce0a219b007b7e42f0e3bbdb5c
https://doi.org/10.1136/ejhpharm-2023-eahp.71
https://doi.org/10.1136/ejhpharm-2023-eahp.71
Publikováno v:
Section 5: Patient safety and quality assurance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95e620f1500ac6c73f42f31bd3fa0d17
https://doi.org/10.1136/ejhpharm-2022-eahp.285
https://doi.org/10.1136/ejhpharm-2022-eahp.285
Publikováno v:
Section 5: Patient safety and quality assurance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0761ca3cc45f6d63b1d5bd41322b7d56
https://doi.org/10.1136/ejhpharm-2022-eahp.305
https://doi.org/10.1136/ejhpharm-2022-eahp.305
Publikováno v:
Section 1: Introductory statements and governance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::510713529c30a03100bf625590972ca9
https://doi.org/10.1136/ejhpharm-2022-eahp.6
https://doi.org/10.1136/ejhpharm-2022-eahp.6
Publikováno v:
Section 5: Patient safety and quality assurance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4e7fdecbf7b3be55221b743020d307a
https://doi.org/10.1136/ejhpharm-2022-eahp.311
https://doi.org/10.1136/ejhpharm-2022-eahp.311